Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a large decline in short interest during the month of July. As of July 31st, there was short interest totaling 3,495 shares, a decline of 63.8% from the July 15th total of 9,653 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 15,605 shares, the days-to-cover ratio is currently 0.2 days.

Arcadia Biosciences Stock Up 7.4%

Arcadia Biosciences stock traded up $0.04 during mid-day trading on Friday, reaching $0.61. The company had a trading volume of 73,183 shares, compared to its average volume of 1,273,635. Arcadia Biosciences has a 52 week low of $0.50 and a 52 week high of $6.71. The firm has a market cap of $1.48 million, a price-to-earnings ratio of -0.11 and a beta of 0.56. The company has a 50 day moving average of $0.73 and a 200-day moving average of $1.21.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.56) by $0.18. Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The firm had revenue of $1.44 million for the quarter, compared to analyst estimates of $1.90 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.